Nisa Investment Advisors, LLC Fate Therapeutics Inc Transaction History

Nisa Investment Advisors, LLC

$15.7 Billion
Q2 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 17,502 shares of FATE stock, worth $54,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,502

Previous 17,137 2.13%

Holding current value

$54,606

Previous $125,000 54.4%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$3.26 - $7.08 $1,189 - $2,584	365 Added 2.13%	17,502 $57,000
Q1 2024 May 01, 2024	BUY	$3.54 - $8.35 $1,051 - $2,479	297 Added 1.76%	17,137 $125,000
Q4 2023 Jan 25, 2024	BUY	$1.65 - $3.94 $25,410 - $60,676	15,400 Added 1069.44%	16,840 $62,000
Q3 2023 Nov 02, 2023	SELL	$2.02 - $5.04 $220 - $549	-109 Reduced 7.04%	1,440 $3,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $18,830 - $26,070	-3,956 Reduced 71.86%	1,549 $7,000
Q1 2023 May 02, 2023	BUY	$4.24 - $11.12 $22,069 - $57,879	5,205 Added 1735.0%	5,505 $31,000
Q4 2022 Feb 02, 2023	SELL	$9.86 - $23.83 $21,317 - $51,520	-2,162 Reduced 87.81%	300 $3,000
Q3 2022 Nov 07, 2022	BUY	$21.04 - $36.06 $7,616 - $13,053	362 Added 17.24%	2,462 $51,000
Q2 2022 Aug 03, 2022	SELL	$17.78 - $42.39 $4,622 - $11,021	-260 Reduced 11.02%	2,100 $52,000
Q1 2022 Apr 29, 2022	SELL	$29.67 - $60.28 $5,340 - $10,850	-180 Reduced 7.09%	2,360 $91,000
Q4 2021 Feb 03, 2022	SELL	$47.84 - $64.34 $17,222 - $23,162	-360 Reduced 12.41%	2,540 $105,000
Q3 2021 Oct 18, 2021	SELL	$59.27 - $95.73 $11,854 - $19,146	-200 Reduced 6.45%	2,900 $172,000
Q2 2021 Aug 06, 2021	SELL	$67.25 - $92.52 $28,917 - $39,783	-430 Reduced 12.18%	3,100 $269,000
Q1 2021 Apr 26, 2021	SELL	$72.16 - $117.4 $28,864 - $46,960	-400 Reduced 10.18%	3,530 $291,000
Q4 2020 Jan 25, 2021	BUY	$38.09 - $100.95 $56,182 - $148,901	1,475 Added 60.08%	3,930 $357,000
Q3 2020 Oct 20, 2020	BUY	$30.41 - $40.5 $57,779 - $76,950	1,900 Added 342.34%	2,455 $98,000
Q2 2020 Jul 27, 2020	BUY	$20.21 - $35.23 $606 - $1,056	30 Added 5.71%	555 $19,000
Q1 2020 Apr 17, 2020	SELL	$17.28 - $31.88 $1,296 - $2,391	-75 Reduced 12.5%	525 $12,000
Q3 2019 Oct 17, 2019	BUY	$15.47 - $22.5 $2,629 - $3,825	170 Added 39.53%	600 $9,000
Q3 2018 Oct 16, 2018	BUY	$8.75 - $16.29 $3,762 - $7,004	430 New	430 $7,000

Others Institutions Holding FATE

# of Institutions

189

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $303M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Fate Therapeutics Inc Transaction History